IP Library › Granted Patent US 7,601,690
Granted Patent B2
US 7,601,690 · App. 11/895,531 · Granted Oct 13, 2009

Cross-linked glycopeptide-cephalosporin antibiotics

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,601,690
App. No.
11/895,531
Granted
Oct 13, 2009
Kind
B2
Abstract

This invention provides cross-linked glycopeptides—cephalosporin compounds and pharmaceutically acceptable salts thereof which are useful as antibiotics. This invention also provides pharmaceutical compositions containing such compounds; methods for treating bacterial infections in a mammal using such compounds; and processes and intermediates useful for preparing such compounds.

Claims (6)

1. A compound of the formula:

2. A pharmaceutically acceptable salt of a compound of the formula:

3. A hydrochloride salt of a compound of the formula:

4. A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a compound of the formula:

5. A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a pharmaceutically acceptable salt of a compound of the formula:

6. A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a hydrochloride salt of a compound of the formula:

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 10, 2014
From: THERAVANCE, INC.
To: THERAVANCE BIOPHARMA ANTIBIOTICS IP, LLC
Reel/Frame 033179/0484 →